Open Access18F-Fluciclovine–Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination
Author(s) -
Franklin Wong,
Lucia Martiniova,
Avantika Masrani,
Gregory Ravizzini
Publication year - 2021
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000003844
Subject(s) - medicine , lymph , axilla , axillary lymph nodes , prostatectomy , prostate cancer , lymphadenectomy , prostate , biochemical recurrence , metastasis , radiology , pathology , cancer , lymph node , breast cancer
A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA COVID-19 vaccination in the ipsilateral arm and the low likelihood of nodal metastases to the axilla from prostate cancer in this patient, the lymph nodes were considered to be benign, reactive to the vaccine.